LOS ANGELES, April 1, 2011 /PRNewswire/ -- UBM Canon and IVD Technology today announced an upcoming webinar in its webcast series on The Fundamentals of In Vitro Diagnostics. This one-hour event will focus specifically on Omics and the Development of IVDs and will offer an in-depth analysis and discussion from experts in the industry.
With the advent of the sequencing of the human genome, scientists have been hard at work seeking correlations between human disease and the architecture of individual genes, gene patterns, cellular pathways, and metabolic events. Such work has brought to the table a host of so called omics - genomics, proteomics, metabolomics - all of which are supposed to play a part in developing a personal genome for individuals.
This webcast will feature presentations by Alexandra Gruber, PhD, Director of Business Development, Biocrates Life Sciences AG; Louisa B. Tabatabai, PhD, Research Chemist, Respiratory Diseases and Immunology Research Unit, National Animal Disease Center, U.S. Department of Agric ulture; and Svetlana A. Dambinova, PhD, Professor at Wellstar College of Health and Human Services, Kennesaw State University. The Webcast concludes with a live Q&A session moderated by Richard Park, Editor-in-Chief of IVD Technology. For more information on the speakers, click here.
Richard Park, Editor-in-Chief of IVD Technology stated, "The editors of IVD Technology have put together an exceptional webcast, bringing together the leading experts in the field of omics who will give presentations and discuss omics-related challenges and issues that IVD manufacturers encounter. This is a rare opportunity to gain insight into the advances in the field of omics."
Attendees will also receive a copy of the DX Directions report on Omics and IVDs, included as a value-add with webcast registration.
The webcast will take place on Thursday, April 21 at 2:00 p.m. ET (1:00 p.m. CT, 11:00 a.m. PT). There is a small registration fee to attend. The event will be archived for six months on the IVD Technology website and UBM Canon Medical Device Media Group's webcast archive. For more information or to register for the webcast, please click here.
About UBM Canon
UBM Canon, the leading B2B media company dedicated exclusively to the global $3.0 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Ca non also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of UBM (UBM.L) a global provider of media and information services for professional B2B communities and markets.
|SOURCE UBM Canon|
Copyright©2010 PR Newswire.
All rights reserved